Carob

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: digestion heart weight

Research Overview

Recent research on carob (Ceratonia siliqua) has focused most heavily on (i) compositional characterization of carob-derived ingredients and products (pulp flour, syrups, fibers, honey, and especially locust bean gum from the seed endosperm), (ii) profiling of bioactive compounds—particularly phenolics such as gallic acid and rutin—using analytical platforms like HPLC, and (iii) in vitro assessment of antioxidant and related bioactivities. A parallel applied literature examines food-technology uses (e.g., locust bean gum as a hydrocolloid thickener across food/pharma/cosmetics; carob flour as a functional ingredient in products such as pasta and jellies) and how processing variables (roasting, extraction method, cultivar/region, and tree gender) influence polyphenol composition and functional properties. There is also a notable body of review work integrating traditional gastrointestinal uses with emerging pharmacological findings.

The strongest evidence supports carob’s value as a fiber-rich food ingredient and as an industrial hydrocolloid (locust bean gum) with well-established water-binding and texturizing functionality. Across multiple product types, carob materials consistently show measurable antioxidant capacity in chemical assays (e.g., DPPH/ABTS/FRAP) that aligns with their phenolic content, and several experimental studies suggest additional bioactivities relevant to metabolic and gastrointestinal health (e.g., antidiabetic potential, anti-inflammatory and antimicrobial effects in GI contexts). However, much of the mechanistic and efficacy evidence remains preclinical: examples include in vitro anti-inflammatory activity (e.g., lipoxygenase inhibition), cytotoxicity signals in colon cancer cell models for roasted-product melanoidins, and animal-model protection (e.g., carob honey mitigating CCl4-induced hepato-renal oxidative injury in rats). Food-fortification studies indicate feasibility and sensory acceptability at modest inclusion levels, while also showing that nutritional/physiological metrics (e.g., predicted glycemic index, starch/protein digestibility, nutrient bioaccessibility) can shift with formulation.

Key gaps include a need for more well-controlled human clinical trials to substantiate health claims (metabolic outcomes, GI indications, cardiometabolic risk markers, and clinically meaningful antioxidant/anti-inflammatory endpoints), along with standardized characterization of interventions (part used, processing, dose, and marker compounds). Additional research is needed to clarify bioavailability and metabolism of carob polyphenols and melanoidins, to reconcile product-to-product variability (cultivar, region, gender, and manufacturing effects), and to establish robust links between compositional markers and in vivo efficacy. Finally, while extraction and analysis methods are actively discussed (with supercritical fluid extraction highlighted as protective for polyphenols), further method optimization and harmonization—plus safety/toxicology and interaction studies for concentrated extracts and formulated products—are required to support pharmaceutical development and evidence-based functional food positioning.

1. What conditions has Carob been studied for?

  • Diabetes / glycemic control: Locust bean gum (carob gum) is described as beneficial for “diabetes” via dietary fiber action, and carob pulp flour is described as having “antidiabetic” activity. A jelly study also characterizes carob pulp flour as containing “natural antidiabetic polyols and polyphenols.”

  • Gastrointestinal (GI) disorders: A review of Tunisian traditional use and modern studies reports GI-related activities including anti-diarrheal, anti-ulcer, anti-constipation, anti-inflammatory, antimicrobial, and “anti-absorptive of glucose” effects in the GI tract.

  • Infant regurgitation / gastroesophageal reflux (GER): Thickened formulas using carob bean gum are reviewed for reducing regurgitation and possibly improving reflux-associated symptoms; a separate study quantifies how carob bean gum thickens infant formula over time and dose.

  • Oxidative stress and toxin-induced organ injury (preclinical): Carob honey was studied in rats for protection against carbon tetrachloride (CCl4)-induced liver and kidney injury.

  • Colon cancer (early/preclinical signals): In vitro work on melanoidin fractions (including from carob) reported cytotoxic effects against SW-480 colon cancer cells and in vitro anti-inflammatory activity (lipoxygenase inhibition).

  • Cardiovascular/heart disease and colon cancer (general claims): One abstract states locust bean gum may help control “heart disease and colon cancer” due to dietary fiber action, but does not provide trial details in the provided text.

  • Antioxidant-related outcomes / phenolic bioaccessibility: Multiple abstracts focus on phenolic profiles (e.g., gallic acid, rutin), antioxidant capacity assays (e.g., DPPH, ABTS, FRAP/ORAC), and changes after in vitro digestion or microencapsulation.

2. Does it work in treating those conditions? Summarize the evidence.

  • Infant regurgitation/GER (best-supported clinically in these abstracts): A review of thickened formulas reports that thickened formulas (including those using carob bean gum) reduce regurgitation, may improve reflux-associated symptoms, and increase weight gain, with effectiveness depending on formula and infant characteristics. The review also notes that commercial thickened formulas are preferred over adding thickeners to standard formula due to viscosity, digestibility, and nutritional balance considerations.

  • GI disorders (supportive but largely non-clinical/summary-level in these abstracts): The GI-focused review concludes carob has “beneficial preventive and therapeutic properties” for the digestive tract and lists multiple pharmacological activities (anti-diarrheal, anti-ulcer, etc.). However, the abstract does not specify human trial outcomes, so the strength of evidence in the provided text is suggestive rather than definitive.

  • Diabetes/glycemic control (mixed and indirect in these abstracts): Several abstracts describe antidiabetic activity and reduced glucose absorption in the GI tract, but the provided text does not include human clinical endpoints. Additionally, a pasta fortification study found that adding 1–5% carob flour increased expected glycemic index (eGI) proportionally (reported range ~72.2 to 83.9), while also decreasing in vitro starch/protein digestibility at 5% substitution (~9% lower than control). Overall, evidence here is not sufficient to conclude clinical glucose-lowering efficacy, and food-matrix effects may vary.

  • Oxidative stress / hepato-renal protection (animal evidence): In rats, carob honey (2 g/kg orally) ameliorated CCl4-induced changes in liver enzymes and kidney function markers and improved oxidative stress parameters (e.g., reduced MDA/PCO/AOPP and improved antioxidant defenses such as CAT, GPx, GSH, ascorbic acid). This is promising but preclinical and specific to a toxin-injury model and to carob honey (not necessarily carob fiber/flour).

  • Colon cancer (in vitro only in these abstracts): Carob melanoidins showed dose- and time-dependent cytotoxicity against SW-480 colon cancer cells and reduced lipoxygenase in vitro. This is early-stage evidence and does not establish efficacy or safety in humans.

  • Antioxidant effects (strong in vitro; uncertain clinical relevance): Multiple studies report antioxidant capacity in chemical assays (DPPH/ABTS/FRAP/ORAC) and identify abundant phenolics (notably gallic acid and rutin). One study suggests microencapsulation can improve bioaccessibility of carob phenolics during simulated digestion. These findings support biological plausibility but do not by themselves prove clinical benefit.

3. What health benefits does it have?

  • High fiber-related benefits (locust bean gum/carob fiber): Locust bean gum is described as beneficial for bowel movements and for control of diabetes, heart disease, and colon cancer “due to its dietary fiber action” (claim-level in the abstract, without trial details).

  • GI support potential: The GI-focused review describes anti-diarrheal, anti-ulcer, anti-constipation, anti-inflammatory, and antimicrobial activities, consistent with traditional use for GI disorders.

  • Antioxidant potential from polyphenols: Several abstracts attribute health-promoting effects to phenolic compounds; HPLC profiling identifies gallic acid and rutin as abundant in some carob products, and multiple products show antioxidant activity in vitro.

  • Functional food/nutrient profile: A survey of traditional carob products characterizes carob as a functional food with low fat, high dietary fiber, and being a source of minerals, though it notes that processed products only partially meet expected health/nutrition claims.

  • Food formulation benefits: Carob flour fortification of pasta increased phenolics and antioxidant measures substantially (e.g., ~2-fold phenolics and ~18-fold antiradical activity at 5% substitution) without significant sensory changes in that study, suggesting a practical route to increase polyphenol intake (while noting glycemic index changes in that same work).

  • Infant feeding benefit (when medically indicated): Thickened formulas using carob bean gum are reviewed as reducing regurgitation and potentially improving reflux-associated symptoms, with attention to correct preparation and product choice.

4. Does it have any downsides or side effects?

  • Infant formula thickening risks/handling issues: A viscosity study found thickening can increase viscosity exponentially from 25% of recommended dosage onward, meaning small dosing errors can markedly change thickness. For carob bean gum, a viscosity plateau was reached only after ~30 minutes, implying that preparation timing matters. The authors highlight the need to match teat size and consider infant sucking energy expenditure, and emphasize parent education for correct dosing and a 30-minute waiting period.

  • Glycemic impact may vary by food matrix: In a wheat pasta study, carob flour substitution (1–5%) increased expected glycemic index (reported range ~72.2 to 83.9 as substitution increased), despite also decreasing in vitro starch/protein digestibility at higher substitution. This suggests that adding carob to foods does not automatically lower glycemic impact.

  • Product variability and labeling limitations: A survey of traditional carob products found substantial variation in nutritional composition depending on ingredients and manufacturing, and only 60% had nutrition labels (with most labeled products consistent). This variability can be a practical downside for consumers trying to achieve specific nutritional targets (e.g., fiber, sugars, minerals).

  • Evidence gaps on adverse effects: The provided abstracts do not report common adult side effects (e.g., GI intolerance) or drug interactions in a systematic way. Safety conclusions therefore depend on data not included here.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The provided abstracts do not report pharmacogenomic findings for carob (e.g., effects modified by genetic variants in metabolism, transporters, or receptors). No specific genetic variations are identified as making carob more beneficial or harmful in these texts.

Given that many reported effects relate to dietary fiber (locust bean gum) and polyphenols (e.g., gallic acid, rutin), it is plausible that individual responses could vary due to genetics influencing digestion, absorption, and metabolism; however, this is not directly addressed in the supplied abstracts, so no evidence-based pharmacogenomic recommendations can be made from this material.

References

  1. Locust bean gum: processing, properties and food applications--a review.
    Sheweta Barak, Deepak Mudgil (2014) - International journal of biological macromolecules
  2. Sensory Evaluation and Consumers' Acceptance of a Low Glycemic and Gluten-Free Carob-Based Bakery Product.
    Luigi Esposito, Nicola Casolani, Marco Ruggeri, Umile Gianfranco Spizzirri, Francesca Aiello, Emilio Chiodo, Maria Martuscelli, Donatella Restuccia, Dino Mastrocola (2024) - Foods (Basel, Switzerland)
  3. Phenolic Profile, Antioxidant Activity, and Chemometric Classification of Carob Pulp and Products.
    Georgia D Ioannou, Ioanna K Savva, Atalanti Christou, Ioannis J Stavrou, Constantina P Kapnissi-Christodoulou (2023) - Molecules (Basel, Switzerland)
  4. Polyphenols in carobs: A review on their composition, antioxidant capacity and cytotoxic effects, and health impact.
    Ioannis J Stavrou, Atalanti Christou, Constantina P Kapnissi-Christodoulou (2018) - Food chemistry
  5. Nutritional, biochemical, and clinical applications of carob: A review.
    Ali Ikram, Waseem Khalid, Khair-Ul- Wajeeha Zafar, Anwar Ali, Muhammad Faizan Afzal, Afifa Aziz, Izza Faiz Ul Rasool, Ammar Al-Farga, Faisal Aqlan, Hyrije Koraqi (2023) - Food science & nutrition
  6. Carob: A Sustainable Opportunity for Metabolic Health.
    Aristea Gioxari, Charalampia Amerikanou, Irini Nestoridi, Eleni Gourgari, Harris Pratsinis, Nick Kalogeropoulos, Nikolaos K Andrikopoulos, Andriana C Kaliora (2022) - Foods (Basel, Switzerland)
  7. Exploring Carob (
    Widad Dahmani, Nabia Elaouni, Abdelhadi Abousalim, Zachée Louis Evariste Akissi, Abdelkhaleq Legssyer, Abderrahim Ziyyat, Sevser Sahpaz (2023) - Plants (Basel, Switzerland)
  8. Plant-Based Ingredients Utilized as Fat Replacers and Natural Antimicrobial Agents in Beef Burgers.
    Silvia Jane Lombardi, Gianfranco Pannella, Francesca Coppola, Franca Vergalito, Lucia Maiuro, Mariantonietta Succi, Elena Sorrentino, Patrizio Tremonte, Raffaele Coppola (2024) - Foods (Basel, Switzerland)
  9. Functional Components of Carob Fruit: Linking the Chemical and Biological Space.
    Vlasios Goulas, Evgenios Stylos, Maria V Chatziathanasiadou, Thomas Mavromoustakos, Andreas G Tzakos (2016) - International journal of molecular sciences
  10. Isolation, structural characterization and biological activity evaluation of melanoidins from thermally processed cocoa beans, carob kibbles and acorns as potential cytotoxic agents.
    Joanna Oracz, Urszula Lewandowska, Katarzyna Owczarek, Miłosz Caban, Justyna Rosicka-Kaczmarek, Dorota Żyżelewicz (2024) - Food chemistry
  11. Effect of carob (Ceratonia siliqua L.) flour on the antioxidant potential, nutritional quality, and sensory characteristics of fortified durum wheat pasta.
    Łukasz Sęczyk, Michał Świeca, Urszula Gawlik-Dziki (2016) - Food chemistry
  12. Nutritional characterization of carobs and traditional carob products.
    Eleni Papaefstathiou, Agapios Agapiou, Stelios Giannopoulos, Rebecca Kokkinofta (2018) - Food science & nutrition
  13. Carob pulp flour as an innovative source of bioactive molecules for the preparation of high-value-added jellies.
    Umile Gianfranco Spizzirri, Luigi Esposito, Paolino Caputo, Maria Martuscelli, Martina Gaglianò, Maria Lisa Clodoveo, Giuseppina De Luca, Cesare Oliverio Rossi, Marco Savastano, Eva Scarcelli, Monica Rosa Loizzo, Donatella Restuccia, Francesca Aiello (2024) - Heliyon
  14. Chemical constituents and pharmacological actions of carob pods and leaves (Ceratonia siliqua L.) on the gastrointestinal tract: A review.
    Kaïs Rtibi, Slimen Selmi, Dhekra Grami, Mohamed Amri, Bruno Eto, Jamel El-Benna, Hichem Sebai, Lamjed Marzouki (2017) - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  15. Carob (
    Mohamad Hesam Shahrajabian, Wenli Sun (2024) - Reviews on recent clinical trials
  16. Antioxidant Activity and Protective Effect of Carob Honey in CCl
    Redouan El-Haskoury, Noori Al-Waili, Zineb Kamoun, Mohamed Makni, Hamza Al-Waili, Badiaa Lyoussi (2018) - Archives of medical research
  17. The viscosity-enhancing effect of carob bean gum and sodium carboxymethylcellulose when added to infant formula.
    Kyara Baert, Mathieu Ombecq, Myriam Van Winckel, Silke Henry, Eline Tommelein, Valérie Vanhoorne (2024) - Food science & nutrition
  18. Effect of in Vitro Gastrointestinal Digestion on Encapsulated and Nonencapsulated Phenolic Compounds of Carob (Ceratonia siliqua L.) Pulp Extracts and Their Antioxidant Capacity.
    Siham Ydjedd, Sihem Bouriche, Rubén López-Nicolás, Teresa Sánchez-Moya, Carmen Frontela-Saseta, Gaspar Ros-Berruezo, Farouk Rezgui, Hayette Louaileche, Djamel-Edine Kati (2017) - Journal of agricultural and food chemistry
  19. Thickened infant formula: What to know.
    Silvia Salvatore, Francesco Savino, Maartje Singendonk, Merit Tabbers, Marc A Benninga, Annamaria Staiano, Yvan Vandenplas (2018) - Nutrition (Burbank, Los Angeles County, Calif.)
  20. Identification, Bioaccessibility, and Antioxidant Properties of Phenolic Compounds in Carob Syrup.
    Melissa Zannini, Alice Cattivelli, Lorenzo Nissen, Angela Conte, Andrea Gianotti, Davide Tagliazucchi (2024) - Foods (Basel, Switzerland)


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!